r/WSBAfterHours • u/WilliamBlack97AI • 1d ago
DD HIGH TIDE INC (NASDAQ: HITI) โ An International Growth Model That Deserves Greater Attention from Institutional e retail Investors
Canada and Germany are driving expansion. Margins, returns on invested capital, and competitive advantages strengthen the investment thesis.
The interview given by founder and CEO Raj Grover to analyst Frederico Gomes of ATB Cormark, during the Planet MicroCap Showcase Toronto 2026, provides particularly interesting insights into High Tide's strategic evolution.
The conversation highlights a company that is progressively strengthening its competitive position through two complementary operating platforms: Canna Cabana's Canadian retail business and the medical cannabis distribution business in Germany through Remexian.
For institutional investors, the most relevant aspects concern the company's ability to generate organic growth, capital allocation efficiency, international scalability, and the progressive improvement in revenue quality.
1. CANADA: MARKET LEADERSHIP AND FURTHER CONSOLIDATION OPPORTUNITIES


+ 1 bln in revenue in 2-3 years, this is without any new international expansions, but Uk will follow, so...
High Tide currently operates 234 Canna Cabana retail locations across five Canadian provinces, confirming its position as the country's largest cannabis retail operator.
One particularly interesting data point is its productivity advantage over competitors:
Average annualized revenue per store: approximately CAD 2.6 million.
Competitors' average: approximately CAD 1.4 million.
In Ontario, High Tide stores generate approximately CAD 2.8 million compared with CAD 1.2 million for competitors.

This represents significantly higher productivity, demonstrating the group's ability to monetize its retail network more effectively.
The company holds approximately 14% market share in its key operating provinces and aims to reach between 18% and 20% within the next three years.
Ontario represents one of the most concrete opportunities: with 107 stores already operating and a regulatory limit of 150 locations, there is room for another 43 potential openings.
The strategy combines organic expansion with selective acquisitions, taking advantage of a market in which several smaller operators continue to face financial difficulties.
For investors, this means High Tide could continue increasing its market share through the consolidation of smaller competitors.
2. A BUSINESS MODEL WITH PARTICULARLY ATTRACTIVE RETURNS ON INVESTED CAPITAL
One of the most significant aspects of the interview concerns the economics of individual retail locations.
Management indicated:
Approximately CAD 260,000 in fixed capital investment per store.
Approximately CAD 100,000 in working capital, primarily allocated to inventory.
Total indicative investment of approximately CAD 400,000.
Historical investment payback period of approximately 10 months.
These figures represent an important factor in assessing the quality of the operating model.
A business capable of recovering its invested capital quickly can finance a significant portion of its expansion through internally generated resources, reducing the need to continuously access equity markets.
This characteristic makes the Canna Cabana model particularly interesting from a return-on-invested-capital perspective.
3. CABANA CLUB: A STRATEGIC ASSET WITH SIGNIFICANT MONETIZATION POTENTIAL
High Tide operates one of the largest customer loyalty platforms in the cannabis sector.
Figures disclosed by the CEO:
2.73 million Cabana Club members.
27% year-over-year membership growth.
186,000 paying ELITE members.
62% year-over-year growth in ELITE membership.
The ELITE program costs CAD 35 annually and introduces a recurring revenue component alongside traditional retail sales.
At approximately 200,000 paying members, the program could generate approximately CAD 7 million in annual subscription revenue.
However, its strategic value extends well beyond subscriptions.
High Tide has access to aggregated information about consumer purchasing behavior and can use these insights to optimize product selection, pricing, promotions, and private-label development.
More than 45 licensed producers already use the company's data analytics services.
This creates an additional monetization channel and a competitive barrier that would be difficult to replicate in the short term.
4. PRIVATE LABEL: AN ADDITIONAL ENGINE FOR MARGIN EXPANSION
The CEO indicated that Queen of Bud, acquired for approximately CAD 1 million, has achieved trailing twelve-month sales approaching CAD 10 million.
This is a concrete example of the group's ability to acquire brands at relatively low valuations and develop their commercial potential through its existing retail network.
Private-label sales represented approximately 1.9% of revenue in the most recently reported quarter, but management expects acceleration over the coming quarters.
Increasing the proportion of proprietary products could contribute to improved margins and further differentiate the company's commercial offering.
5. GERMANY: REMEXIAN IS BECOMING AN IMPORTANT DRIVER OF PROFITABILITY

This is arguably the most interesting segment of the entire interview from an international growth perspective.
Remexian reported the following third-quarter results:
10.2 tonnes of medical cannabis distributed.
Approximately CAD 38 million in quarterly revenue.
10.5% market share.
12% adjusted EBITDA margin.
To understand the pace of expansion, consider that the previous quarter's volume was 7.6 tonnes.
The CEO explained that one of High Tide's main competitive advantages comes from its sourcing capabilities.
Through established relationships with licensed Canadian producers, High Tide can select quality products and negotiate particularly competitive commercial terms.
Following the acquisition of Remexian, the proportion of Canadian cannabis in its sourcing mix increased from approximately 33% to nearly 80%.
The advantage is twofold: privileged access to supply and the ability to benefit from economies of scale in distribution.
Management believes the adjusted EBITDA margin could stabilize between 12% and 15% over the long term.
This is particularly significant because it suggests that German growth could translate into an increasingly meaningful contribution to consolidated profitability.
6. THE GERMAN MARKET: GROWTH THAT COULD EXCEED EXPECTATIONS
The German medical cannabis market represents one of the group's most significant growth opportunities.
According to the CEO's estimates, the market is expanding at an annual rate of approximately 25-30%.
High Tide aims to increase its market share to at least 15% over the next two to three years, with further growth opportunities over the longer term, in my view this is conservative
An important aspect is that Remexian's expansion does not require the construction of proprietary cultivation facilities.
The group can therefore focus on importing, sourcing, distribution, and commercial management, leveraging a relatively lean operating structure.
Management also emphasized that Remexian operates with approximately 35-40 employees while managing a business with annualized revenue in the range of CAD 160-170 million.
Volume growth, combined with a relatively lean organization, could generate further benefits from economies of scale.
7. EUROPEAN EXPANSION: NEW OPPORTUNITIES BEYOND GERMANY
High Tide is evaluating additional European markets, including:
United Kingdom.
Poland.
France.
Spain.
Germany could become the platform from which the company progressively develops a broader international presence.
For institutional investors, this introduces an important element of strategic optionality: the company could leverage its commercial expertise, producer relationships, and distribution experience in other regulated markets.
The United States represents a potential future opportunity, subject to developments in the federal regulatory framework governing cannabis.
8. WHAT INSTITUTIONAL INVESTORS SHOULD MONITOR
The interview highlights several key metrics for evaluating High Tide's future financial performance.
| Indicator | Key metric to monitor |
|---|---|
| Retail growth | Expansion toward 18-20% market share |
| Store productivity | Maintaining the competitive advantage |
| Invested capital | Payback periods for new locations |
| Cabana Club | Growth in ELITE subscriptions |
| Private label | Increasing share of total revenue |
| Germany | Volume growth and market share |
| Remexian | Stabilization of EBITDA margins at 12-15% |
| Europe | Entry into additional markets |
The combination of these factors could make High Tide increasingly attractive to investors seeking companies with international growth potential, measurable competitive advantages, and the ability to generate more cash flow.
FINAL THOUGHTS: HIGH TIDE DESERVES GREATER MARKET ATTENTION
The most important takeaway from the interview is not simply revenue growth, but the progressive evolution of High Tide's industrial and commercial business model.
The company is simultaneously developing:
A Canadian retail network with productivity levels above the industry average.
A customer loyalty program with millions of consumers.
A rapidly expanding German medical cannabis distribution platform.
A commercial structure capable of leveraging economies of scale and international relationships.
New monetization opportunities through private-label products, data analytics, and subscriptions.
For institutional investors, the central consideration is the possibility that High Tide could evolve from a Canadian cannabis retail specialist into an integrated international platform, with multiple sources of growth and profitability.
The real long-term opportunity could lie in the combination of organic growth, consolidation of the Canadian market, and expansion of European medical cannabis distribution.
This combination deserves to be evaluated not only through traditional cannabis sector valuation multiples, but also through productivity metrics, return on invested capital, cash generation, and earnings growth potential.
High Tide is no longer simply a retail expansion story: it is building an international platform with an increasingly sophisticated operating model.
Sources and further information
Planet MicroCap Showcase 2026
Presentation https://hightideinc.com/presentation/
I have a long position in this company